Connection

John Lazarchick to Protein Kinase Inhibitors

This is a "connection" page, showing publications John Lazarchick has written about Protein Kinase Inhibitors.
Connection Strength

0.136
  1. Pan-PIM kinase inhibitors enhance Lenalidomide's anti-myeloma activity via cereblon-IKZF1/3 cascade. Cancer Lett. 2019 01; 440-441:1-10.
    View in: PubMed
    Score: 0.136
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.